Azathioprine in Relapsing-Remitting Multiple Sclerosis
  • View Times: 27
  • |
  • Release Date: 2023-09-01
  • azathioprine
  • relapsing-remitting multiple sclerosis
  • first-line disease-modifying therapy
  • dimethyl fumarate
  • interferon beta-1a
  • teriflunomide
Video Introduction

This video is adapted from 10.3390/brainsci13091249

Azathioprine (AZA) has demonstrated efficacy in multiple randomized control trials (RCTs) for Relapsing-Remitting Multiple Sclerosis (RRMS).

Full Transcript
©Text is available under the terms and conditions of the Creative Commons-Attribution ShareAlike (CC BY-SA) license; additional terms may apply. By using this site, you agree to the Terms and Conditions and Privacy Policy.
Video Production Service
Feedback